Report: Drug Discovery Industry Review TOC

INTRODUCTION/SUMMARY

BCC ON-LINE SERVICES
- INTERNET

ARTIFICIAL CELLS

THE SYNTHETIC GENOME PROJECT
POWER SUPPLY FOR ARTIFICIAL CELLS
- POWER SUPPLY FOR ARTIFICIAL CELLS (CONTINUED)

BASIC SCIENCE

GROWTH HORMONE KEEPS OLD RATS FIT
TOO MANY BACTERIA CAUSE ULCERS
- TOO MANY BACTERIA CAUSE ULCERS (CONTINUED)
HIV-LIKE VIRUS IN WILD CHIMPS
TURNING OFF INFLAMMATION
POLYOMA VIRUS LINKED TO BRAIN TUMORS
- POLYOMA VIRUS LINKED TO BRAIN TUMORS (CONTINUED)
MOUSE MODEL FOR MYELOID LEUKEMIA
SUPER-STAPH INVADES HOSPITALS WORLDWIDE
ENTER THE VISIBLE MOUSE
- ENTER THE VISIBLE MOUSE (CONTINUED)
SUPRESSING GENES IN C. ELEGANS
CELL MIGRATION KEY TO SCHIZOPHRENIA
HELPING FRUIT FLIES TO REMEMBER
NEW THEORY OF DRUG ACTION
SPIN RESONANCE REVEALS STRUCTURE
LIPID ACTIVATES CLOT FORMATION
RAT MODEL OF EPILEPSY CREATED
THERMOGENESIS MAY BE KEY TO OBESITY
MOTOR PROTEIN AMPLIFIES SOUND
GECKOS EMPLOY VAN DER WAALS FORCE
- GECKOS EMPLOY VAN DER WAALS FORCE (CONTINUED)
PLASMON WAVEGUIDES FOR STUDYING MEMBRANES
PLASMON RESONANCE MEASURES BINDING
'SMART DUST' SENSES BIOMOLECULES
- 'SMART DUST' SENSES BIOMOLECULES (CONTINUED)

BIOINFORMATICS

GRID-COMPUTING ENABLES RESEARCH
DIAGNOSTIC TOOLS TO BE DEVELOPED
MALARIA PARASITE, MOSQUITO SEQUENCED
- MALARIA PARASITE, MOSQUITO SEQUENCED (CONTINUED)
AWARD FOR CHEMICAL INTELLIGENCE PLATFORM
GRANT AWARDED FOR "COMPUTATIONAL BIOLINGUISTICS"
- GRANT AWARDED FOR "COMPUTATIONAL BIOLINGUISTICS" (CONTINUED)
NANOBARCODES USED TO SCORE SNPs
WEBSITE OFFERS SNP INFO

BIOMIMETICS

NATURE TO SHOW NASA THE WAY
TINY ORGANIC MUSCLES, TENDONS AND PUMPS
CORRALLING THE WILD MAGNETIC VORTEX
- CORRALLING THE WILD MAGNETIC VORTEX (CONTINUED)
SILVER BINDING PEPTIDES GENERATE CRYSTALS

COLLABORATIONS

TRANS-PACIFIC ARTHRITIS DEAL
PROFILING DEAL FOR HIV INFECTION
ADA, ENTELOS SET DIABETES FORUM
INHALE TO PEGYLATE THROMBOPOIETIN
JOINT EFFORT TO FIND GCPR LIGANDS
MUSCULAR DYSTROPHY COLLABORATIVE DEAL
SINGLE CHAIN ANTIBODY AGREEMENT
AGREEMENT COVERS PROTEOSOME INHIBITORS
DRUG SALVAGE OPERATION BEGUN
TRANS-PACIFIC PROTEOMICS PACT
DRUG DISCOVERY CONTRACT SIGNED
AVIVA AND AXON ANNOUNCE AGREEMENT
DARK SIDE OF THE GENOME EXPLORED
DECLARING WAR ON ANTIBIOTIC RESISTANCE
MS CLINICAL RESEARCH AGREEMENT
COLLABORATION ADDS INVERSE GENOMICS
NEOGENESIS LAUNCHES TWO COLLABORATIONS
- NEOGENESIS LAUNCHES TWO COLLABORATIONS (CONTINUED)

COMPUTING

FERRITIN USED TO CREATE STORAGE MEDIA

CONFERENCE REPORT

NANOTECH, BIOTECH CONVERGE IN CT
- NANOTECH, BIOTECH CONVERGE IN CT (CONTINUED)
- NANOTECH, BIOTECH CONVERGE IN CT (CONTINUED)
- NANOTECH, BIOTECH CONVERGE IN CT (CONTINUED)
- NANOTECH, BIOTECH CONVERGE IN CT (CONTINUED)

DESIGNER MACROMOLECULES

RNA INTERFERENCE COLLABORATION INITIATED
DESIGNER POLYMERS THAT SELF-ASSEMBLE
- DESIGNER POLYMERS THAT SELF-ASSEMBLE (CONTINUED)
AMBION WINS SIRNA GRANT
MANUFACTURING MESH WITH MICROBIAL MOLECULES
- MANUFACTURING MESH WITH MICROBIAL MOLECULES (CONTINUED)

DIAGNOSTICS AND ANALYTICS

U.S. MARKET FOR BIOSENSORS AND BIOELECTRONICS TO CROSS $1.81 BILLION BY 2006

Table 1 U.S. MARKET FOR BIOSNESORS AND BIOELECTRONICS, THROUGH 2006 ($ MILLIONS)
Figure 1 U.S. MARKET FOR BIOSNESORS AND BIOELECTRONICS, 2001 AND 2006 ($ MILLIONS)
- US. MARKET FOR MEDICAL IMAGING AND RELATED PRODUCTS TO REACH NEARLY $10 BILLION BY 2007
Table 2 U.S. USER EXPENDITURES FOE MEDICAL IMAGING EQUIPMENT AND RELATED PRODUCTS, THROUGH 2007 ($ MILLIONS)
Figure 2 U.S. USER EXPENDITURES FOE MEDICAL IMAGING EQUIPMENT AND RELATED PRODUCTS, 2000-2007 ($ MILLIONS)
- GLUTAMINE SYNTHETASE MARKS ALZHEIMER'S
- STOOL TEST FOR COLON CANCER
  - STOOL TEST FOR COLON CANCER (CONTINUED)
- DETECTING INFECTION BY SUBTRACTION
- PATTERNS REVEAL OVARIAN CANCER
- BLOOD TEST FOR CONGESTIVE HEARTS
- SYNTHETIC ANTIBODIES USED AS SENSORS
- BRANCHED-CHAIN HEP C TEST
- RIGHTS TO OVARIAN TUMOR MARKERS
- PROTEIN ASSOCIATED WITH CANCER
- NANOPARTICLES USED TO FINGERPRINT PATHOGENS
  - NANOPARTICLES USED TO FINGERPRINT PATHOGENS (CONTINUED)
- DNA SEPARATION BY SIEVE
- DETECTION DEVICE FOR BIOWARFARE AGENTS
- TATTOO TO MONITOR BLOOD GLUCOSE LEVELS
- PCR IN SUB-NANOLITER VOLUMES
- CONNECTING TITANIUM DIOXIDE TO DNA
- MICROFLUIDIC DEVICE TO DETECT MULTIPLE VIRUSES
- VERTICAL CAVITY SURFACE EMITTING LASER BUILT
- QUANTUM DOTS MAKE FROGS FLUORESCENT
- GRANT FOR MICROFLUIDIC DEVICES
  - GRANT FOR MICROFLUIDIC DEVICES (CONTINUED)

DRUG AND VACCINE DELIVERY

NANOPARTICLE DELIVERS TO THE EYE
HYDROFLUOROALKANE FOR DELIVERING DRUGS
IMPLANT DELIVERS DRUGS TO EYE
GO AHEAD-INHALE, IT'S LEGAL
TESTS SPEED HIV, HCV DIAGNOSIS
DEPOMED SUES BRISTOL-MYERS SQUIBB
MAKING MICROSPHERES FOR DRUG DELIVERY
IMPLANT BLOCKS VASOSPASM
PROTEIN AND PEPTIDE DELIVERY SYSTEM
INHALEABLE PEPTIDE SUBJECT OF COLLABORATION
EAT YOUR CORN, IT'S GOOD FOR YOU
ENCAPSULATION PROCESS PATENTED
LIGHT PULLS LIQUID THROUGH TUBES
CHIPS FOR DRUG DELIVERY
QUANTUM DOTS HOME ON CANCER
TREATING CANCER WITH MRI PROCEDURE
MOLECULAR TRANSPORTERS OPEN CELL'S GATES
PATENT FOR BIOSILICON ISSUED
PARTICLES ACT AS ADJUVANT
NUCLEIC ACID-TRIGGERED DRUG RELEASE
ISOLATED ORGANELLE AS A VACCINE
ANTIBODIES ADDED TO NANOPARTICLE CARRIERS
- ANTIBODIES ADDED TO NANOPARTICLE CARRIERS (CONTINUED)

DRUG DISCOVERY

NANOVOLUME CRYSTALLIZATION YIELDS STRUCTURES

DRUG TARGETS

INHIBITOR AND BLOCKER MARKET TO CROSS $176 BILLION BY 2006

Table 3 WORLDWIDE MARKET FOR INHIBITORS AND BLOCKERS, THROUGH 2006 ($ MILLIONS)
Figure 3 WORLDWIDE MARKET FOR INHIBITORS AND BLOCKERS, 2001 AND 2006 ($ MILLIONS)
- TUMORS DEPEND ON POLYAMINE
- TRP TRNA SYNTHETASE IS ANTI-ANGIOGENIC
- ANGIOGENESIS INHIBITOR BINDS TO INTEGRIN
  - ANGIOGENESIS INHIBITOR BINDS TO INTEGRIN (CONTINUED)
- TARGETS FOR CANCER THERAPY PATENTED
- PROTEIN ESSENTIAL FOR HIV ASSEMBLY
- WATER TRANSPORT IN THE LUNG
- ENZYME PROMOTES MULTIPLE SCLEROSIS
- TNF-ALPHA AFFECTS CELL DEATH
  - TNF-ALPHA AFFECTS CELL DEATH (CONTINUED)
- LEPTIN PROMOTES BLOOD CLOTS
- GENE LINKED TO VENTRICLE FORMATION
- ENZYME REPAIRS OXIDATIVE DAMAGE
  - ENZYME REPAIRS OXIDATIVE DAMAGE (CONTINUED)
- POLYMERASE ERRORS CAUSE MUSCLE DISEASE
- MANGANESE BLOCKS HIV REPLICATION
- ACID-ACTIVATED PROTEIN PLAYS ROLE IN LEARNING
  - ACID-ACTIVATED PROTEIN PLAYS ROLE IN LEARNING (CONTINUED)
- COMPLEX DRIVES PLATELET SHAPE
- SUPPRESSOR MISSING IN PROSTATE CANCER
- QUORUM SENSING STRUCTURE SOLVED
- FINDING SIGNALS FOR OBESITY
- DRUG RESISTANCE PATENT ISSUED
- HUNTINGTON'S DISRUPTS BRAIN MITOCHONDRIA
  - HUNTINGTON'S DISRUPTS BRAIN MITOCHONDRIA (CONTINUED)

IMAGING

MEDICAL SENSORS FROM NANOANTENNAS
ZOOMING OUT WITH LEAP
POTATO HEAD PARTICLE LIGHTS UP PLAQUES
COATING MAKES MRI IMPLANTS SAFE
YES, VIRGINIA, THERE IS A SANTA CLAUS
VIEWING ATOMIC MAGNET FIELDS

IMPLANTS

CANTILEVER BATTERY TO POWER IMPLANTS
NITINOL DEVICE DOES HEAVY LIFTING
- NITINOL DEVICE DOES HEAVY LIFTING (CONTINUED)

INDUSTRY NEWS

MARKET FOR DRUGS AND COSMETICS CONTINUE TO TAP THE AGING BABY BOOMERS GENERATION

Table 4 VALUE OF THE AGING BABY BOOMER PHARMACEUTICAL & COSMETIC SALES ¾ U.S., THROUGH 2006 ($ MILLIONS AT MANUFACTURERS' LEVEL)
Figure 4 VALUE OF THE AGING BABY BOOMER PHARMACEUTICAL & COSMETIC SALES ¾ U.S., 2001 AND 2006 ($ MILLIONS AT MANUFACTURERS' LEVEL)
- MARKET FOR REPRODUCTIVE TECHNOLOGIES CONTINUES TO EVOLVE IN THE COMING YEARS
Table 5 MARKET FOR REPRODUCTIVE TECHNOLOGY PRODUCTS AND PROCEDURES, THROUGH 2006 ($ MILLIONS)
Figure 5 MARKET FOR REPRODUCTIVE TECHNOLOGY PRODUCTS AND PROCEDURES, 2001 AND 2006 ($ MILLIONS)
- WORLDWIDE DIABETES MARKET TO CROSS $26.8 BILLION BY 2007
Table 6 WORLDWIDE DIABETES MARKET, THROUGH 2007 ($ MILLIONS)
Figure 6 WORLDWIDE DIABETES MARKET, 2000-2007 ($ MILLIONS)
- U.S. MARKET FOR MEDICAL DIAGNOSTIC KITS TO CROSS $5 BILLION BY 2006
Table 7 U.S. MDK APPLICATIONS MARKET AT U.S. MANUFACTURERS' SALES LEVELS, THROUGH 2006 ($ MILLIONS)
Figure 7 U.S. MDK APPLICATIONS MARKET AT U.S. MANUFACTURERS' SALES LEVELS, 2001 AND 2006 ($ MILLIONS)
- GLOBAL MARKET FOR PHARMACEUTICAL (DRUG) INERT INGREDIENTS TO REACH NEARLY 4.2 BILLION KGS BY 2006
  - GLOBAL MARKET c BY 2006 (CONTINUED)
Table 8 GLOBAL MARKET FOR PHARMACEUTICAL (DRUG) INERT INGREDIENTS, THROUGH 2006 (MILLIONS OF KG)
- U.S. GENERIC PRESCRIPTION DRUG INDUSTRY TO CROSS $19 BILLION BY 2006
Table 9 THE U.S. GENERIC DRUG MARKET, THROUGH 2006 ($ BILLIONS)
Figure 8 PERCENTAGE OF THE U.S. GENERIC DRUG MARKET HELD BY LEADING THERAPEUTIC CATEGORIES, 2001
- THE $400 BILLION WORLDWIDE DRUG INDUSTRY CONTINUES TO EVOLVE
  - REPORT FINDINGS
Table 10 TRENDS IN DRUG SALES, THROUGH 2007 ($ BILLIONS)
- CONTRACT FOR BIOTERROR CONTROL
- BURRILL OPENS SHOP ON BIOSTREET
- CARDIOME ACQUIRES PARALEX, HEART DRUG
- FIRST LICENSING OF APTAMERS
- BUSH BUDGETS FOR BIOTERROR MEASURES
  - BUSH BUDGETS FOR BIOTERROR MEASURES (CONTINUED)
- PRIVATE ACCREDITATION FOR HUMAN CLINICALS
- AUSTRALIAN BIOTECH GETS A NEWS OUTLET
- HOMELAND HEALTH OFFERS BIOPREPAREDNESS
- BATTLE IN SEATTLE OVER ENBREL
- WHAT MAKES ALCOHOLICS DRINK?
- IVAX BUYS MERCK'S GENERICS BUSINESS
- NO ECONOMIES OF SCALE
- YAMANOUCHI COMES TO AMERICA
- AUSTRALIAN STEM CELLS AVAILABLE
- APOPTOSIS GOES COMMERCIAL
- AGING INSTITUTE FUNDS COMPANY
- SULFATION PATHWAYS FOCUS OF NEW FIRM
- MORE AUTONOMY FOR PHARMA UNITS
- DESPITE OBSTACLES, BIOTECH MARCHES ON
  - DESPITE OBSTACLES, BIOTECH MARCHES ON (CONTINUED)
- BRISTOL-MYERS SUED AGAIN
- BIOVAIL LICENSES METFORMIN PRODUCT
- GENENTECH TO PAY $300 MILLION
- MERCK TO REFILE ARCOXIA NDA
- PHRMA SUES FEDERAL GOVERNMENT
- U.S. AIDS FOUNDATION TAKES ON GLAXO
- QUARK ACQUIRES INCYTE'S MICROARRAY ASSETS
- REALITY DEPRESSES AIDS RESEARCHERS
- MEDICINES FOR AGING AMERICANS
- DOES THE INDUSTRY NEED ANOTHER MERGER?
  - DOES THE INDUSTRY NEED ANOTHER MERGER? (CONTINUED)
- ENGINEERING AND LIFE SCIENCES CONVERGING
- ROCHE LICENSES ALZHEIMER'S COMPOUNDS
- CHINA ESTABLISHES NANOTECHNOLOGY CENTER
- BIOTECH FIRM SPUN OUT OF COVENTOR
- GRANT TO BUILD NANOTECH CENTER
- IS U.S. BEING OUTSPENT TWO TO ONE ON NANO?
- NANOGEN, COMBIMATRIX SETTLE SUIT
- ZYVEX, HONEYWELL TEAM UP
- SANDIA TO FOCUS ON LIFE SCIENCES
  - SANDIA TO FOCUS ON LIFE SCIENCES (CONTINUED)
- NANO READY TO MOVE, SAYS U.K. SURVEY
- PENN STATE GETS NEW NANOSCIENCE CENTER
- SMALL TECH HITS THE BIG TIME
- SHOULD THE GENIE BE KEPT BOTTLED?
- NANOSPHERE BAGS VC FUNDS
- CARBON NANOTECH GROUP FORMED IN TAIWAN
- TRITON BIOSYSTEMS SWALLOWS THERMONIX
- BRIEFLY NOTED
  - CEPHEID AND APPLIED BIOSYSTEMS GROUP TO DEVELOP AND MARKET REAGENTS
  - GENEMACHINES LAUNCH OMNIGRID 300 MICROARRAYER
  - CAPSULUTION NANOSCIENCE AND DEUTSCHE GELATINE-FABRIKEN STOESS AG, EBERBACH SIGNED AGREEMENT.
  - METRICS GROUP PUBLISH TECHNICAL INTELLIGENCE PROFILE REPORT
  - STARPHARMA GET U.S. PATENT OK
  - BIOFORCE NANOSCIENCES RECEIVE TOTAL EQUITY INVESTMENT
  - OXFORD BIOSENSORS TO PROGRESS FROM PRODUCT DEVELOPMENT INTO PRODUCT MANUFACTURE

INDUSTRY OUTLOOK

DISCOVERY, TECHNOLOGY AND DRUGS TO COME
- DISCOVERY, TECHNOLOGY AND DRUGS TO COME (CONTINUED)
- DISCOVERY, TECHNOLOGY AND DRUGS TO COME (CONTINUED)
- DISCOVERY, TECHNOLOGY AND DRUGS TO COME (CONTINUED)
- DISCOVERY, TECHNOLOGY AND DRUGS TO COME (CONTINUED)

INFORMATICS

DRAFT MOUSE SEQUENCE AVAILABLE
FROM CHEMICAL TO CLINICAL
HUNTINGTON'S DISEASE GENE DATABASE
LINKING IMAGES TO EXPERIMENTAL DATA
- LINKING IMAGES TO EXPERIMENTAL DATA (CONTINUED)
PENNSYLVANIA CREATES BIOINFORMATICS CONSORTIUM
VISUALIZATION OF DRUG INTERACTIONS
SUPERCOMPUTER CRUNCHES AWAY FOR TULARIK
HUMAN HAPLOTYPE MAP TO BE CREATED
OF MICE, MEN AND THEIR GENES
- OF MICE, MEN AND THEIR GENES (CONTINUED)

MEMS AND NEMS

RESTORING SIGHT WITH RETINAL IMPLANTS
TRANSATLANTIC MEMS CO-OPERATION
- TRANSATLANTIC MEMS CO-OPERATION (CONTINUED)

MODELING

IMAGINING AND MODELING THE INVISIBLE
SOFTWARE FOR MODELING MATERIALS

NANOASSEMBLY

STACKING TINY PARTS ELECTRONICALLY

NANOPARTICLES

MINING GOLD WITH ALFALFA
ALTAIR WINS TIO2 PATENT

NANOTUBES AND NANOWIRES

NANOWIRE NANOLASERS FOR NANOSYS
CATALYSTS CONTROL NANOTUBE DIAMETERS
- CATALYSTS CONTROL NANOTUBE DIAMETERS (CONTINUED)
OPTICAL PROPERTIES OF NANOTUBES

NEW COMPOUNDS

SYNTHETASE INHIBITOR STOPS FUNGUS
HEPATITIS C PROTEASE INHIBITOR DEVELOPED
ANTAGONIST TO TREAT PARKINSON'S
MICROSPHERES MAY HEAL FOOT ULCERS
RIGHT ISOMER BETTER THAN WRONG ISOMER
- RIGHT ISOMER BETTER THAN WRONG ISOMER (CONTINUED)
CHINESE HERBS IN PHASE II TRIALS
HIV DRUG WORKS AGAINST HEP B
THREE CANDIDATES FROM OSI
- THREE CANDIDATES FROM OSI (CONTINUED)
PHENSERINE REDUCES ALZHEIMER'S PLAQUES
ULTRASOUND-ACTIVATED DRUG FOR CANCER
PEPTIDE MIMETICS LICENSED FROM PENN
SCORPION TOXIN IS BRAIN TUMOR ANALOGUE
ROCHE LICENSES SYNTHETIC EPO
CLINICAL TRIAL FOR CANNABINOID COMPOUND
ANTIBIOTIC ACQUIRED BY PANTHERIX
PHASE III TRIALS OF HEPATITIS B DRUG
COMBRESTATIN INHIBITS OCULAR BLOOD VESSELS
PATENTS RELATED TO MYOSTATIN APPROVED
ADENOSINE AGONISTS FOR SEPSIS
NDA FILED FOR ZELAPAR
ANTIVIRAL RNA ENTITIES PATENTED
GRAPE JUICE IS GOOD FOR YOU
- GRAPE JUICE IS GOOD FOR YOU (CONTINUED)
PEPTIDE PROMOTES NERVE GROWTH
GLUTAMATE RECEPTOR AGONISTS LICENSED
CYCOLOSPORIN ANALOGS PASS TESTS
RATS REGAIN FUNCTION AFTER STROKE
SCORPION TOXIN IS ORPHAN DRUG
ESPERION WINS HDL PATENT
FDA PANEL SUPPORTS HEP B APPROVAL
FEMFLURAMINE ACTIVATES MELANOCORTIN NEURONS
IND SOUGHT FOR GLYXINS
- IND SOUGHT FOR GLYXINS (CONTINUED)

OLD COMPOUNDS

AYURVEDIC COMPOUND LOWERS CHOLESTEROL

PATENTS

NANOSYS LICENSES UC BERKELEY IP
MEMS, NEMS PATENT PROFILES AVAILABLE
INTELLECTUAL PROPERTY TOUGH TO PROTECT

PEPTIDES

MIRROR IMAGES ARE ACTIVE ANTIMICROBIALS

PROTEOMICS

COMBINING BIOLOGY WITH MASS SPEC
MAP OF YEAST PROTEOME PUBLISHED
NANOFAB MAKES NANOPROTEOMICS ARRAYS
PHOSPHORYLATION SITES CATALOGED
TRUNCATED CF PROTEIN IS FUNCTIONAL
NMR CHARACTERIZES PROTEIN BINDING SITES
ATHERSYS PATENTS RAGE TECHNOLOGY
PROTEIN NETWORKS IN MUSCLE DISEASES
Q-TRAP MASS SPECTROMETER
PROTEOME SYSTEMS JAPAN LAUNCHED
GRANT AWARDED FOR MEDICINE NETWORK
FILTER SEPARATES PROTEINS AND DNA
ZYOMYX FORMS PROTEOMIC ALLIANCE
EMPLOYMENT OF ACTIVITY- BASED CHEMICAL PROBES
GENETIX GROUP LANDS PROTEOMICS GRANT
IDENTIFYING MEMBRANE AND SECRETED PROTEINS

RATIONAL DRUG DESIGN

CHLORIDE CHANNEL STRUCTURE DETERMINED
HITTING STRUCTURALLY CONSERVED DOMAINS
- HITTING STRUCTURALLY CONSERVED DOMAINS (CONTINUED)

SCREENING

VIRTUAL SCREENING OF TOXIN INHIBITORS
"MONOPHORE" SCREENING TECHNIQUE PATENTED
DESIGN YOUR OWN MICROFLUIDICS CHIP
NANOLITHOGRAPHY BUILDS DNA ARRAYS
NANOTECH BIOTERROR SENSORS DEVELOPED
SCREENING FOR ANTIFUNGALS
- SCREENING FOR ANTIFUNGALS (CONTINUED)

SEMICONDUCTORS

IBM BUILDS MOLECULAR SCALE TRANSISTOR

THIN FILMS

COBRA SEES THIN FILMS AT ATOMIC RESOLUTION

LIST OF TABLES

Table 1 U.S. MARKET FOR BIOSNESORS AND BIOELECTRONICS, THROUGH 2006 ($ MILLIONS)
Table 2 U.S. USER EXPENDITURES FOE MEDICAL IMAGING EQUIPMENT AND RELATED PRODUCTS, THROUGH 2007 ($ MILLIONS)
Table 3 WORLDWIDE MARKET FOR INHIBITORS AND BLOCKERS, THROUGH 2007 ($ MILLIONS)
Table 4 VALUE OF THE AGING BABY BOOMER PHARMACEUTICAL & COSMETIC SALES ¾ U.S., THROUGH 2006 ($ MILLIONS AT MANUFACTURERS' LEVEL)
Table 5 MARKET FOR REPRODUCTIVE TECHNOLOGY PRODUCTS AND PROCEDURES, THROUGH 2006 ($ MILLIONS)
Table 6 WORLDWIDE DIABETES MARKET, THROUGH 2007 ($ MILLIONS)
Table 7 U.S. MDK APPLICATIONS MARKET AT U.S. MANUFACTURERS' SALES LEVELS, THROUGH 2006 ($ MILLIONS)
Table 8 GLOBAL MARKET FOR PHARMACEUTICAL (DRUG) INERT INGREDIENTS, THROUGH 2006 (MILLIONS OF KG)
Table 9 THE U.S. GENERIC DRUG MARKET, THROUGH 2006 ($ BILLIONS)
Table 10 TRENDS IN DRUG SALES, THROUGH 2007 ($ BILLIONS)

LIST OF FIGURES

Figure 1 U.S. MARKET FOR BIOSNESORS AND BIOELECTRONICS, 2001 AND 2006 ($ MILLIONS)
Figure 2 U.S. USER EXPENDITURES FOE MEDICAL IMAGING EQUIPMENT AND RELATED PRODUCTS, 2000-2007 ($ MILLIONS)
Figure 3 WORLDWIDE MARKET FOR INHIBITORS AND BLOCKERS, 2002 AND 2007 ($ MILLIONS)
Figure 4 VALUE OF THE AGING BABY BOOMER PHARMACEUTICAL & COSMETIC SALES ¾ U.S., 2001 AND 2006 ($ MILLIONS AT MANUFACTURERS' LEVEL)
Figure 5 MARKET FOR REPRODUCTIVE TECHNOLOGY PRODUCTS AND PROCEDURES, 2001 AND 2006 ($ MILLIONS)
Figure 6 WORLDWIDE DIABETES MARKET, 2000-2007 ($ MILLIONS)
Figure 7 U.S. MDK APPLICATIONS MARKET AT U.S. MANUFACTURERS' SALES LEVELS, 2001 AND 2006 ($ MILLIONS)
Figure 8 PERCENTAGE OF THE U.S. GENERIC DRUG MARKET HELD BY LEADING THERAPEUTIC CATEGORIES, 2001